Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Low calcium channel inhibitors: modalities for use].

C Abdelkhirane1, J Clementy

  • 1Hôpital Cardiologique du Haut Lévéque, Bordeaux-Pessac.

Annales De Cardiologie Et D'Angeiologie
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Flecainide-induced Increase in QRS Duration and Proarrhythmia during Exercise.

Clinical drug investigation·2016
Same author

[Catheter ablation for atrial fibrillation].

Annales de cardiologie et d'angeiologie·2010
Same author

[Recommendations from the French Cardiology Society concerning the competence, performance and the environment required for the implantation and surveillance of pacemakers].

Archives des maladies du coeur et des vaisseaux·2006
Same author

[Identification of candidates for multisite pacing: results and presumed mechanisms of action after five years experience].

Archives des maladies du coeur et des vaisseaux·2006
Same author

[Mapping and ablation of malignant ventricular arrhythmias].

Archives des maladies du coeur et des vaisseaux·2006
Same author

[Characterization of premature ventricular contraction initiating ventricular fibrillation].

Archives des maladies du coeur et des vaisseaux·2005
Same journal

[Study of Sleep Apnea Syndrome in Patients with Chronic Heart Failure in the Cardiology Department at Yalgado Ouédraogo teaching hospital in 2024 and 2025].

Annales de cardiologie et d'angeiologie·2026
Same journal

[Impact of knowledge and practices of hygieno-dietetical measures in hypertensive people at the Abidjan cardiology institute].

Annales de cardiologie et d'angeiologie·2026
Same journal

[Correlation between carotid atheroma and DAS28 gamma GT score in rheumatoid arthritis in an African black population].

Annales de cardiologie et d'angeiologie·2026
Same journal

[Dobutamine stress echocardiography: Appropriateness of indications and protocol compliance. A single-centre report].

Annales de cardiologie et d'angeiologie·2026
Same journal

[Post-COVID postural orthostatic tachycardia syndrome: Documentation of a hyperadrenergic phenotype by comprehensive autonomic testing].

Annales de cardiologie et d'angeiologie·2026
Same journal

Urban-rural disparities in hypertension prevalence, screening, and control in South Kivu Province, eastern Democratic Republic of the Congo.

Annales de cardiologie et d'angeiologie·2026
See all related articles

New calcium channel inhibitors offer diverse therapeutic options in cardiology. This review guides selection based on mechanism, tissue selectivity, pharmacokinetics, and formulation for optimal patient outcomes.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine

Context:

  • Emerging calcium channel inhibitors present new treatment avenues.
  • Their expanding applications necessitate a review of their role in cardiovascular therapy.

Purpose:

  • To clarify the position of calcium channel inhibitors in cardiology.
  • To guide the selection of appropriate calcium channel inhibitors.

Summary:

  • Discusses factors influencing the choice of calcium channel inhibitors, including mechanism of action, tissue selectivity, pharmacokinetics, and available formulations.
  • Provides an overview of calcium channel inhibitors for medical treatment.

Impact:

  • Aids clinicians in selecting the most suitable calcium channel inhibitor.

Related Experiment Videos

  • Supports evidence-based decision-making in cardiovascular pharmacotherapy.